Ator, Mark A. External Author

Publications

Sort by

Selected publications

  • CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancersMolecular Cancer Therapeutics2012 Academic Article GET IT
    Times cited: 47